Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Karabou, Abdoulaye
Bisseux, Laurence
Pavese, Ida
Collon, Thierry
机构：
[1] Montfermeil Hosp, GHT Grand Paris Est, Med Oncol Unit, Montfermeil, France
[2] GHI LE Raincy Montfermeil, Montfermeil, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21585
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Perioperative Nivolumab in non-small cell Lung Cancer
    Lorenz, Judith
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (18) : 1065 - 1066
  • [42] Practical effectiveness efficacy and safety of nivolumab for advanced non-small cell lung cancer: A retrospective multicenter analysis
    Kobayashi, K.
    Nakachi, I.
    Naoki, K.
    Oyamada, Y.
    Nakamura, M.
    Inoue, T.
    Tateno, H.
    Sakamaki, F.
    Sayama, K.
    Terashima, T.
    Koh, H.
    Arai, D.
    Yasuda, H.
    Kawada, I.
    Soejima, K.
    Betsuyaku, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Efficacy of Single-Agent Chemotherapy after Exposure to Nivolumab in Advanced Non-Small Cell Lung Cancer
    Yasuda, Y.
    Funazo, T.
    Nomizo, T.
    Tsuji, T.
    Yoshida, H.
    Sakamori, Y.
    Nagai, H.
    Ozasa, H.
    Hirai, T.
    Kim, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2076 - S2076
  • [44] Neoadjuvant Nivolumab and Chemotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Zhai, Hengyu
    Li, Wenhai
    Jiang, Kun
    Zhi, Yanan
    Yang, Zhao
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 515 - 524
  • [45] Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients
    Sarocchi, Matteo
    Grossi, Francesco
    Arboscello, Eleonora
    Bellodi, Andrea
    Genova, Carlo
    Dal Bello, Maria Giovanna
    Rijavec, Erika
    Barletta, Giulia
    Rossi, Giovanni
    Biello, Federica
    Ghigliotti, Giorgio
    Canepa, Marco
    Mussap, Michele
    Brunelli, Claudio
    Spallarossa, Paolo
    ONCOLOGIST, 2018, 23 (08): : 936 - 942
  • [46] Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Shimokawa, T.
    Nakamura, Y.
    Iwasawa, S.
    Miyazaki, K.
    Yamanaka, T.
    Takiguchi, Y.
    Okamoto, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2431 - S2431
  • [47] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Feasibility study of nivolumab and docetaxel in previously treated patients with advanced non-small cell lung cancer
    Miyazaki, Kazuhito
    Iwasawa, Shunichiro
    Nakamura, Yukiko
    Shimokawa, Tsuneo
    Yamanaka, Takeharu
    Takiguchi, Yuichi
    Okamoto, Hiroaki
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease
    Kanai, Osamu
    Kim, Young Hak
    Demura, Yoshiki
    Kanai, Makiko
    Ito, Tsuyoshi
    Fujita, Kohei
    Yoshida, Hironori
    Akai, Masaya
    Mio, Tadashi
    Hirai, Toyohiro
    THORACIC CANCER, 2018, 9 (07) : 847 - 855
  • [50] Evaluation of safety and efficacy of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer.
    Zhang, XT
    Li, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 639S - 639S
12345